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ABSTRACT
Background. C-reactive protein (CRP) is a non-speciﬁcmarker of inﬂammation that has been associ-
ated with depression and vascular disease, particularly inmen. This study aimed to investigate the as-
sociation between high CRP concentration and depression while taking physical health into account.
Method. A cross-sectional study of a community-dwelling sample of 5438 men aged 70+.
Participants with scoreso7 on the 15-item Geriatric Depression Scale (GDS-15) were considered to
display clinically signiﬁcant depressive symptoms. We measured the serum concentration of CRP
with a high-sensitivity assay. The assessment of physical co-morbidity included three components :
the Charlson weighted index, self-report of major health events on a standardized questionnaire,
and the physical component of the 36-item Short-Form Health Survey (SF-36). Other measured
factors included age, native language, education, a standardized socio-economic index, smoking,
prior or current history of depression treatment, cognitive impairment (Mini-Mental State
Examination score<24) and body mass index (BMI).
Results. Participants with depression (n=340) were older than their controls without depression
(age in years : 76.6¡4.4 v. 75.4¡4.1). Men with CRP concentration>3 mg/l had an increased odds
ratio (OR) [1.59, 95% conﬁdence interval (CI) 1.20–2.11] of being depressed compared to men with
CRP f3 mg/l. This association became non-signiﬁcant once we adjusted the analysis for the
measures of physical co-morbidity and other confounding factors (OR 1.22, 95% CI 0.86–1.73).
Conclusions. The physiological mechanisms that lead to the onset and maintenance of depressive
symptoms in older men remain to be determined, but CRP concentration is unlikely to play a
signiﬁcant role in that process.
INTRODUCTION
Depression is a leading cause of disability world-
wide, aﬀecting 2–5% of the adult population
(Regier et al. 1988). The pathophysiology of
depression is uncertain and is probably varied
and complex, but current evidence suggests
that inﬂammation is likely to be involved in at
least some cases (Ford & Erlinger, 2004). This
hypothesis is supported by the fact that inﬂam-
mation has also been involved in the patho-
physiology of atherothrombosis (Ross, 1999;
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Verma et al. 2006), and depression in later
life has been associated with an increased risk
of atherothrombotic risk factors and sequelae
(e.g. cerebrovascular disease) (Alexopoulos
et al. 1997; Thomas et al. 2004). Furthermore,
inﬂammatory changes have been observed in
the blood vessels of people with depression,
particularly in later life (Thomas et al. 2005).
C-reactive protein (CRP) is a commonly used
non-speciﬁc marker of low-grade inﬂammation
that has been prospectively associated with in-
creased risk of cardiovascular disease (Danesh
et al. 2004). High levels of CRP have also been
linked to depression. Kop et al. (2002) found
that older people with depression (n=510) had
signiﬁcantly higher CRP than non-depressed
subjects (n=3750). Further cross-sectional stud-
ies have conﬁrmed that high CRP is associated
with increased risk of depression in young and
older adults (see review by Kuo et al. 2005), but
questions remain as to the causal role of CRP
on the development of depression. For example,
the ﬁndings from the Rotterdam study suggest
that the association between CRP and de-
pression may be explained by age, gender, edu-
cation, use of antidepressants and, importantly,
poor health (Tiemeier et al. 2003b). In other
words, high CRP could simply indicate the
presence of an ongoing process of deteriorating
physical health, which, in turn, increases the
risk of depression. As a result, the association
between CRP and depression in later life can
only be adequately investigated by studies that
measure physical health in a systematic way and
that have suﬃcient statistical power to take its
presence into account.
We designed this study to determine the
association between CRP concentration and
the presence of clinically signiﬁcant depression
in a community-dwelling sample of older adults.
Based on the ﬁndings from the Rotterdam study
(Tiemeier et al. 2003b), we hypothesized that the
association between CRP and depression is en-
tirely explained by poor physical health.
METHOD
Recruitment of the study cohort
Our analyses are based on data from a pro-
spective cohort investigation of older male resi-
dents of Perth, Western Australia, the Health
in Men Study (HIMS). Details regarding the
enrolment of participants have been described
elsewhere (Jamrozik et al. 2000). In brief, 12 203
men aged 65 years or older were recruited
by random sampling from the Australian elec-
toral roll between 1996 and 1998, enrolment to
vote being compulsory for all adult Australian
citizens. The participants represented 70.5%
of all eligible invitations issued. During the
years 2001–2004, those men who were still alive
were contacted and invited for a follow-up
assessment. This report refers to those who were
still alive and consented to follow-up. The study
was approved by the Human Research Eth-
ics Committee of the University of Western
Australia.
Procedures and assessment
Consenting men were asked to complete a
self-report questionnaire that included items
assessing demographic and clinical information.
Age was calculated as the diﬀerence in years
between the date of the assessment and the
subject’s date of birth. Participants were con-
sidered to come from a non-English-speaking
background (NESB) if they reported that the
ﬁrst language they learnt as a child was not
English. Education was rated as the highest level
of education attained: no schooling, primary
school, some high school, completed high
school, completed university or other tertiary
degree. We used subjects’ postcodes to generate
the Socio-Economic Indicator for Areas
(SEIFA) Index: ratings lower than 1000 indicate
relative socio-economic disadvantage (Bray,
2001).
Subjects were asked to indicate whether or
not they had ever smoked [Have you ever
smoked cigarettes, cigars or a pipe regularly?
(yes/no)] and whether they were still smoking at
the time of the assessment [How often do you
smoke now? (every day/not every day/not at all)].
Men were considered to be current smokers
if they answered ‘every day’ or ‘not every day’.
Participants were then asked whether they
had been previously treated for an emotional or
nervous illness such as depression (yes/no) and
whether they were having treatment (pills or
psychotherapy) for an emotional or nervous ill-
ness such as depression now (yes/no).
All men were requested to complete the 15-
item Geriatric Depression Scale (GDS-15) and,
a priori, those with a total score of 7 or more
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were considered to display clinically signiﬁcant
depressive symptoms (point prevalence). This
relatively high cut-oﬀ point was chosen to en-
sure high speciﬁcity for the diagnosis of de-
pression in this sample (Almeida & Almeida,
1999). A trained research nurse then admin-
istered the Mini-Mental State Examination
(MMSE; Folstein et al. 1975), with scores lower
than 24 indicating the presence of cognitive im-
pairment (Crum et al. 1993).
Measurement of physical co-morbidity
The assessment of physical co-morbidity in-
volved three components. First, we used the
Charlson weighted index (Charlson et al. 1987)
to determine the presence of signiﬁcant medical
co-morbidity in our sample. We obtained ad-
ministrative medical information from the
Western Australian (WA) Linked Database
(Holman et al. 1999). In brief, the Database
links together records of all hospital admissions
(private and public) since 1980 with the Mental
Health Information System (MHIS), WA can-
cer register, WA death register and WA hospital
morbidity data (which includes all admissions to
private and public hospitals). We obtained
linked data for all participants until the end of
2004, which was the time of the last assessment
at HIMS. Coding algorithms to deﬁne co-
morbidities followed the procedures described
by Quan et al. (2005) and were calculated using
Stagg’s Stata routine to calculate the Charlson
index (StataCorp, 2006).
Second, as part of the assessment for HIMS,
men were asked whether they had ever been
advised by a doctor that they had had a myo-
cardial infarction (yes/no), stroke (yes/no), or
any of the following surgical procedures
(yes/no) : open heart surgery, carotid endar-
terectomy, bypass surgery to the aorta or leg
arteries, abdominal surgery, hip or knee re-
placement, lung surgery, brain surgery, prostate
surgery, major neck surgery and surgery on the
oesophagus.
Third, participating men used the 36-item
Short-Form Health Survey (SF-36) to rate their
health (Ware et al. 2000). For the purposes of
this study, the analyses were limited to the
physical component summary (PCS) measure.
The mean PCS for the Australian population is
50, with a standard deviation of 10 (ABS, 1995).
Participants with PCS f40 were considered to
have poor perceived physical health at the time
of the assessment (i.e. 1 standard deviation or
more below the mean of the population).
Biochemical analyses
HIMS participants were invited to donate a
fasting blood sample for biochemical analyses.
We measured the serum concentration of CRP
with a high-sensitivity assay that used a particle-
enhanced immunonephelometry system on a
BNII analyser (Dade Behring, Birmingham,
UK). The interassay coeﬃcient of variation
(CV) for this test ranges from 4% to 7%. CRP
concentration>3 mg/l has been associated with
a twofold increased relative risk of cardio-
vascular events (Pearson et al. 2003). Therefore,
we considered that men in our study with CRP
>3 mg/l had ‘high CRP’.
Analysis of data
The data were analysed with the statistical
package Stata release 9.2 (StataCorp, 2006).
Participants were divided into two groups ac-
cording to whether or not they met the study
criterion for clinically signiﬁcant depressive
symptoms. We used Student’s t test to compare
the diﬀerences between the groups for age and
theMann–Whitney test for serum concentration
of CRP. We measured the association between
ranked ordinal variables with the Spearman
correlation coeﬃcient (Spearman’s r). We cal-
culated odds ratios (ORs) and respective 95%
conﬁdence intervals (CIs) from 2r2 tables to
measure the strength of the association between
demographic, clinical and biochemical charac-
teristics of participants and CRP concentration
grouping (according to quartiles and the cut-
point of 3 mg/l). We then used multiple logistic
regression to clarify whether the association be-
tween CRP and depression, as measured by the
OR, could be explained by other measured fac-
tors.
RESULTS
Of the 5438 men who completed the self-rating
questionnaire at the follow-up assessment for
HIMS in 2001–2004, 340 (6.2%, 95% CI
5.6–6.9%) reported clinically signiﬁcant de-
pressive symptoms (GDS score o7) and 4245
had a venous blood sample taken. Subjects who
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scored within the depression range were 2.17
(95% CI 1.71–2.74) times less likely to consent
to blood tests, and men who did not have a
blood test had a higher weighted Charlson
index than those who did (z=6.01, p<0.001).
Subjects with depression were also older than
their non-depressed counterparts [mean¡stan-
dard deviation (S.D.) : 76.6¡4.4 v. 75.4¡4.1,
t=5.08, p<0.001, range 70–88 years]. Other
demographic and clinical characteristics of the
sample are displayed in Table 1.
The distribution of CRP data was positively
skewed and although skewness of the data di-
minished after logarithmic transformation, the
variable remained unﬁt for parametric analysis
(Shapiro–Wilk test for normality z score=
13.79, p<0.001). Median CRP concentration
was signiﬁcantly higher among men who
were depressed than those who were not [2.5
(95% CI 2.2–2.8) v. 1.8 (95% CI 1.8–1.9) ;
Mann–Whitney z statistic=4.04, p<0.001].
There was a very weak direct correlation be-
tween depression scores and CRP concentration
(Spearman r=0.09, p<0.001). There was also
a modest association between the weighted
Charlson index and PCS score (Spearman’s
r=–0.26, p<0.001).
We divided participants into four groups to
explore the relationship between depression/
physical co-morbidity and CRP (Fig. 1). The
ﬁrst group of men showed no evidence of clini-
cally signiﬁcant depression or physical co-
morbidity (n=1666) and had a median CRP
concentration of 1.6 mg/l (binomial 95% CI
1.6–1.7). The group with clinically signiﬁcant
depression but no physical co-morbidity (n=24)
had a median CRP concentration of 1.3 mg/l
(binomial 95% CI 0.9–4.9). The third group of
men had signiﬁcant physical co-morbidity but
no depression (n=3435), and a median CRP
concentration of 2.0 mg/l (binomial 95% CI
1.9–2.0). The last group included men who met
the study’s criteria for depression and physical
co-morbidity (n=313) ; they had a median CRP
Table 1. Demographic and clinical characteristics of subjects with and without clinically
signiﬁcant depressive symptoms, as determined by the 15-item Geriatric Depression Scale (GDS-15)
Demographic/clinical characteristics
GDS-15<7 (n=5098) GDS-15o7 (n=340)
OR 95% CIn % n %
Non-English-speaking background 715 14.1 74 21.9 1.70 1.28–2.24
Education: completed at least high school 2380 46.7 125 36.8 0.66 0.52–0.84
Disadvantaged area of residence 1572 32.1 124 37.0 1.24 0.98–1.57
Ever smoker 3337 65.5 269 79.3 2.02 1.54–2.69
Current smoker 252 4.9 31 9.1 1.93 1.26–2.87
Obese (BMIo30) 584 14.6 51 24.6 1.91 1.35–2.68
Cognitive impairment (MMSE<24) 504 13.6 50 27.6 2.43 1.69–3.44
Previous treatment for depression 442 8.8 103 30.9 4.65 3.58–6.02
Current treatment for depression 176 3.5 54 16.2 5.34 3.77–7.47
Charlson’s index (weighted)
0 2326 47.1 85 25.2 1
1–2 1646 33.3 114 33.8 1.89 1.42–2.53
3–4 624 12.6 76 22.5 3.33 2.41–4.60
5+ 341 6.9 62 18.4 4.97 3.52–7.04
Ever stroke 470 9.7 78 23.9 2.94 2.21–3.87
Ever myocardial infarction 829 17.0 86 26.4 1.74 1.33–2.27
Major surgical procedure 4520 90.1 300 90.1 1.00 0.69–1.50
SF-36 PCS scoref40 1962 40.3 236 78.7 5.47 4.10–7.37
CRP quartile
<1.01 mg/l 1019 25.5 39 18.3 1
1.01–1.87 mg/l 1014 25.3 44 20.7 1.13 0.73–1.76
1.88–3.82 mg/l 994 24.8 57 26.8 1.50 0.99–2.27
>3.82 mg/l 973 24.3 73 34.3 1.96 1.32–2.92
CRP>3 mg/l 1261 31.5 90 42.2 1.59 1.20–2.11
OR, Odds ratio; CI, conﬁdence interval ; BMI, body mass index; MMSE, Mini-Mental State Examination; SF-36, 36-item Short-Form
Health Survey; PCS, physical component summary; CRP, C-reactive protein.
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concentration of 2.5 mg/l (binomial 95% CI
2.2–3.1) (Fig. 1). Men with no depression or
physical co-morbidity (group 1) had a signiﬁ-
cantly lower CRP concentration than men with
no depression and physical co-morbidity
(z=–5.95, p<0.001) (group 3), or men with de-
pression and physical co-morbidity (z=–5.83,
p<0.001) (group 4). Participants with de-
pression associated with physical co-morbidity
(group 4) had a higher CRP concentration than
men with physical co-morbidity but no de-
pression (z=–3.38, p=0.004) (group 3). There
were no signiﬁcant diﬀerences between any
other two groups. All analyses were adjusted for
multiple comparisons using the Bonferroni
method.
We used logistic regression to clarify whether
the association between CRP and depression
remained after adjusting for age (in years),
NESB, education, disadvantaged area of resi-
dence, smoking status, cognitive impairment,
previous or current treatment for depression,
the weighted Charlson index of co-morbidity,
history of stroke, myocardial infarction or ma-
jor surgery, and PCS score f40 (Table 2). The
highest CRP quartile was associated with at
least a 19% increase in the risk of depression
(lower conﬁdence limit for the crude OR), but
the association between CRP and depression
weakened once physical health was taken into
account (Table 2, models 3 and 4). We per-
formed an additional analysis to investigate the
association between depression and CRP, but
this time adjusting the results for the measures
of physical co-morbidity only (i.e. no other
measured factors were included in the analysis).
The association between CRP and depression
was no longer statistically signiﬁcant (OR
1.23, 95% CI 0.61–1.53; for the highest CRP
quartile).
CRP concentration >3 mg/l was detected in
1361 subjects (32.1%). Men with high CRP
were more likely to display clinically signiﬁcant
depressive symptoms (31.4% v. 42.2%; OR
1.59, 95% CI 1.20–2.11). This association re-
mained statistically signiﬁcant after the analyses
were adjusted for age (in years), NESB, edu-
cation, disadvantaged area of residence, smok-
ing status, cognitive impairment, and previous
or current treatment for depression (Table 2,
models 1 and 2). However, the association be-
tween high CRP and depression was no longer
statistically signiﬁcant when measures of physi-
cal co-morbidity were included in the models
(Table 2, models 3 and 4).
Finally, we investigated whether the associ-
ation between depression and high CRP would
change with increasing severity of depressive
symptoms (i.e. greater speciﬁcity for the diag-
nosis of depression). The increase in the cut-
points of the GDS-15 was associated with
progressive decline in the OR associated with
high CRP, culminating in a non-signiﬁcant
univariate association between the two when
GDS-15 scores reached 10 (OR 1.28, 95% CI
0.81–2.02).
DISCUSSION
The results of this study show that the serum
concentration of CRP is only weakly associated
with depression scores in older men (Spearman’s
correlation r=0.09). They also demonstrate
that the association between CRP and the
presence of clinically signiﬁcant depressive
symptoms can be explained by the presence of
other factors, most notably poor physical
health.
CRP is a moderate predictor of coronary
heart disease and, apart from periods of acute
illness, its concentration remains relatively
stable over time (Ridker et al. 1997; Danesh
et al. 2004). There is evidence that older people
with impaired grip strength, decreased walking





























FIG. 1. Boxplots displayed according to group membership. The
solid blocks represent the 25th to 75th centile of C-reactive protein
(CRP) concentration for each group. The white horizontal lines
across the boxes represent the median CRP concentration.
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physical activity have higher CRP than non-frail
individuals, even after the exclusion of subjects
with established cardiovascular disease and
diabetes (Walston et al. 2002). Moreover, high
CRP is associated with increased mortality in
later life (Gruenewald et al. 2006). These ﬁnd-
ings are consistent with the possibility that CRP
is but a biomarker of underlying poor physical
health, although some investigators have sug-
gested CRP may play a causal role in athero-
thrombosis (Verma et al. 2006) and, through
activation of the complement system, lead to
neuronal dysfunction and death. In a recent re-
view of the topic, Raison et al. (2006) speculated
that the complex interaction between depression
and inﬂammatory markers is mediated by
stress-responsive pathways involving the neuro-
endocrine and autonomic nervous systems, and
that depression might be a behavioural by-
product of early adaptive advantages conferred
by genes that promote inﬂammation. Kuo et al.
(2005), however, suggested that high CRP trig-
gers a cascade of events that results in cerebral
atherosclerosis, microangiopathy, disruption of
fronto-subcortical circuits, loss of motivation
and depression. This model is based on the vas-
cular depression hypothesis put forward by
Alexopoulos et al. (1997) that postulates that
depression in later life is the result of cer-
ebrovascular disease, although our previous
ﬁndings suggest that the contribution of
cardiovascular factors to the development of
depression in later life is minimal (Almeida et al.
2007).
According to the model of Kuo et al. (2005),
high CRP should predate the development of
depression. However, currently available data
on the association between depression and CRP
are limited to cross-sectional studies, making it
impossible to establish a temporal relationship
between the presence of high CRP and the onset
of depression. In addition, the results of studies
published to date indicate that the association
between serum concentration of CRP and de-
pression is equivocal, and our ﬁndings show
that it is possible that high CRP might in fact
contribute to a decrease in the risk of depression
in older men. Table 3 summarizes the ﬁndings of
observational studies that investigated the as-
sociation between CRP and depression. Only
two of the 13 reports indicated that high CRP
increases the risk of depression. Penninx et al.
(2003) found that older men and women with
CRP o3.17 mg/l (greater than the highest
quartile) were 1.48 (95% CI 1.04–2.11) times
more likely to score 16 or more on the Center
for Epidemiologic Studies Depression Scale
(CES-D). The analysis was adjusted for a num-
ber of variables, but not for current physical
health. Likewise, Suarez (2004) reported that
subjects with a score of 10 or more on the Beck
Depression Inventory (BDI) had higher serum
concentrations of CRP than participants with
scores lower than 10, although the analysis
was not adjusted for confounding. Kop et al.
(2002) published the ﬁrst and largest study
investigating the association between CRP and
depression in later life. They recruited a sample
Table 2. Odds ratios of clinically signiﬁcant depression according to CRP concentration
CRP group
Crude Model 1 Model 2 Model 3 Model 4
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Reference:
CRP<1.01 mg/l
1.01–1.87 mg/l 1.13 (0.73–1.76) 1.21 (0.77–1.89) 0.91 (0.55–1.51) 0.84 (0.49–1.41) 0.79 (0.46–1.35)
1.88–3.82 mg/l 1.50 (0.99–2.27) 1.55 (1.01–2.37) 1.38 (0.87–2.21) 1.31 (0.81–2.12) 1.13 (0.69–1.84)
>3.82 mg/l 1.96 (1.32–2.92) 1.95 (1.30–2.93) 1.54 (0.98–2.43) 1.27 (0.80–2.04) 1.04 (0.64–1.69)
Reference:
CRPf3 mg/l
CRP>3 mg/l 1.59 (1.20–2.11) 1.57 (1.18–2.08) 1.48 (1.07–2.05) 1.35 (0.96–1.90) 1.22 (0.86–1.73)
OR, Odds ratio; CRP, C-reactive protein; CI, conﬁdence interval.
Model 1: adjusted for age, non-English-speaking background (NESB), education, disadvantaged area of residence.
Model 2: adjusted for age, NESB, education, disadvantaged area of residence, and prior or current smoking, obesity, prior or current
treatment for depression, cognitive impairment.
Model 3: adjusted for age, NESB, education, disadvantaged area of residence, prior or current smoking, obesity, prior or current treatment
for depression, cognitive impairment, and weighted Charlson’s index group, prior history of stroke, myocardial infarction or major surgery.
Model 4: adjusted for age, NESB, education, disadvantaged area of residence, prior or current smoking, obesity, prior or current treatment
for depression, cognitive impairment, weighted Charlson’s index group, prior history of stroke, myocardial infarction or major surgery, and
physical component summary (PCS) scoref40.
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Table 3. Summary of observational studies investigating the association between C-reactive protein (CRP) and depression
Author and
year of
publication Study design Characteristics of the study sample Depression criteria
Other measured variables
included in the analysis
Reported association
between depression and CRP
Kop et al. 2002 Cross-sectional 5888 Medicare-eligible American
men and women aged 65 years or
over. The analyses excluded
subjects with history suggestive of







Age, gender, ethnicity, height,
weight, blood pressure, diabetes,
smoking, physical activity and
physical strength
Subjects with depression had higher
serum concentration of CRP, but
this diﬀerence disappeared after




Cross-sectional 4703 community-dwelling men and
women aged 55 years or over
(Rotterdam Study). 263 screened
positive, of whom 250 received a
diagnostic work-up. 461 subjects
who screened negative on the
CES-D were randomly selected






Age, gender, smoking, history of
stroke and functional disability
The OR of depression associated
with 1 S.D. increase in CRP was
1.01 (95% CI 0.86–1.18) for
CES-Do16 and 1.09 (95% CI
0.90–1.33) for a DSM-IV
depressive disorder
Penninx et al. 2003 Cross-sectional 3075 Medicare-eligible American
men and women aged 70–79 years
free of functional impairment or
life-threatening diseases. Data were
available for 3024 subjects
CES-D scoreo16 Age, ethnicity, study site, smoking,
alcohol consumption, body fat
mass, lung or heart disease,
diabetes, arthritis, use of
anti-inﬂammatory drugs
High CRP (o3.17 mg/l) was
associated with increased odds of
depression (OR 1.48, 95% CI
1.04–2.11)
Note : the authors indicated that the
CRP cut-oﬀ of 3.17 mg/l
represented the median CRP, but
as data reported in the paper show
that the 75% CRP quartile was
3.14 mg/l, the cut-oﬀ chosen was
greater than the highest CRP
quartile
Danner et al. 2003 Cross-sectional 7681 people aged 17–39 years
recruited for the National Health
and Nutrition Examination
Survey. The study oversampled
African and Mexican Americans.





excluded. 6100 people were
available for analysis




Age, ethnicity, BMI, smoking




Participants were divided into two
groups according to whether or not
their CRP was within the
detectable range of the assay
(>2.2 mg/l). Men, but not women,
with detectable CRP had increased
odds of depression in the past
month compared to men who had
never had depression (OR 3.81,



















publication Study design Characteristics of the study sample Depression criteria
Other measured variables
included in the analysis
Reported association
between depression and CRP
Ford & Erlinger,
2004
Cross-sectional Same cohort as Danner et al. 2003,
but including a total of 8435
people. 6914 subjects were
available for analysis




Age, ethnicity, BMI, smoking
status, alcohol use, education, total
cholesterol, triglycerides, systolic
blood pressure, diabetes, aspirin
and ibuprofen use, oestrogen use
for women, and self-reported
health status
Men with detectable CRP
(o2.2 mg/l) had increased odds
of meeting criteria for major
depression during the past year
(OR 3.00, 95% CI 1.39–6.48), but
there was no such association for




Cross-sectional 3355 randomly selected
community-dwelling men and
women, of whom 453 men (mean
age=45¡13 years) and 400
women (mean age=44¡18 years)
completed the depression rating
scale (total n=853)
ZDRS No adjustments made Spearman correlation between
ZDRS and CRP concentration was
0.18, p=0.038
Douglas et al. 2004 Cross-sectional 696 men and women (mean
age=44¡2 years) recruited as part
of the USA Prospective Army
Coronary Calcium Project.
Subjects with history suggestive of
coronary heart disease or with
CRP>10 mg/l were excluded
PHQ-9 BMI, gender, mean arterial blood
pressure, and fasting insulin
Adjusted correlation coeﬃcient
between depression and CRP was
r=0.05, p=0.219
Suarez, 2004 Cross-sectional Convenience sample of 127 men and
women (mean age=27.6¡9.6
years) recruited from the
community through
advertisements. Subjects with prior
psychiatric history, infections or
injuries occurring during the 30
days prior to assessment or using
hormone replacement therapy and
over-the-counter medications
(including aspirin) were excluded
BDI Age and BMI Subjects with BDIo10 had higher
concentration of serum CRP than
subjects with BDI<10 (t=2.18,
p=0.03, not adjusted). Log
normalized CRP was signiﬁcantly
correlated with BDI scores
(r=0.22, p<0.01; adjusted for age
and BMI only)
Thomas et al. 2005 Cross-sectional 19 subjects with major depression
and MADRS>20, 20 subjects
with previous major depression
and 7>MADRS>20, and 21
subjects with no previous





Age and gender There was no diﬀerence between the

















Loucks et al. 2006 Cross-sectional 380 men and 425 women recruited
from a larger sample (n=1189)
of healthy older adults aged 70–79
HSCDS No adjustments made Subjects in the highest CRP quartile
(>3.19 mg/l) did not have an
increased odds of depression
(increase of 1 unit in the HSCDS):
OR 1.01, 95% CI 0.93–1.09 for
men, and high CRP was




Cross-sectional 2640 men and 2628 women recruited
from the 1966 Finish Birth Cohort
Study (total n=12 058). All
subjects were aged 31 years





Alcohol intake, BMI, smoking
systolic blood pressure, physical
inactivity
Men with depression scores in the
moderate (OR 1.4, 95% CI
1.0–1.9) and severe (OR 1.7, 95%
CI 1.1–2.9) range were more likely
to have CRP concentration
o1.0 mg/l compared with men
who had never been depressed.
Men with mild depression or
women with depression across the
various ranges of severity were not
more likely than those who had




Cross-sectional Subsample from the Cardiovascular
Risk in Young Finns Study
(n=3596), of whom 488 men and
713 women agreed to assessment
with the BDI and CRP in 2001
BDI Age, gender, education, BMI,
dietary fat, smoking, alcohol,
physical activity, triglycerides,
HDL cholesterol, LDL cholesterol,
systolic blood pressure, and recent
infection
BDI scores and CRP had poor
correlation (r=0.09). The
regression coeﬃcient of BDI scores
on CRP was low (0.05, p=0.359),
once confounding was taken into
account. Participants with CRP
o3 mg/l were more likely to have
BDI scores>1 S.D. above the mean
than BDI scores<1 S.D. below the
mean (OR 1.07, 95% CI
1.02–1.11), but this analysis was
not adjusted for confounding
BDI, Beck Depression Inventory; BMI, body mass index; CES-D, Center for Epidemiologic Studies Depression Scale ; CI, conﬁdence interval ; df, degrees of freedom; DIS, Diagnostic
Interview Schedule ; HDL, high density lipoprotein ; HSC-25, 25-item Hopkins Symptom Checklist ; HSCDS, Hopkins Symptom Checklist Depression Subscale ; LDL, low density lipoprotein ;















of 5888 men and women older than 65 years
who were free of signiﬁcant cardiovascular dis-
ease. Subjects with a 10-item CES-D score o10
had higher serum concentration of CRP than
those who were not depressed, but this diﬀer-
ence became non-signiﬁcant once the analysis
was adjusted for age, gender, ethnicity, height,
weight, blood pressure, diabetes, smoking,
physical activity and physical strength (p=
0.249). Other studies that included a measure of
current physical function in the investigation of
the association between CRP and depression
were equally negative (Tiemeier et al. 2003a ;
Ford & Erlinger, 2004).
The results of our study should be interpreted
in light of its strengths and limitations. This
survey has the merit of having used a large
and well-established community representative
sample of older people for whom a wealth of
relevant clinical information was available. We
also used a well-validated scale and a demand-
ing cut-point to establish the presence of de-
pression in this sample. Previous studies have
shown that such an approach is associated with
high speciﬁcity and positive predictive values
for the diagnosis of major depression according
to ICD-10 and DSM-IV criteria (Almeida &
Almeida, 1999). In addition, we used a com-
prehensive measure of physical health that
included information obtained from adminis-
trative health data (weighted Charlson index),
self-report of previous major health events (such
as stroke, myocardial infarction and surgery)
and subjective rating of physical health (SF-36
PCS score). This enabled us to adjust carefully
for physical health when investigating the as-
sociation between CRP concentration and de-
pression. Despite our eﬀorts to retrieve detailed
information about the physical health of
participants, we are aware that some events
might have been under-reported. For example,
Anderson et al. (1993) showed that up to 40%
of older adults who have a stroke are not ad-
mitted to hospital in Western Australia. This
would have resulted in a lower Charlson index
although the self-reports may have helped us
to avoid missing such events in our study. Over-
all, the statistical adjustments made for poor
physical health in the analysis of the association
between CRP concentration and depression
are likely to have been conservative, and further
highlight the importance of these ﬁndings
(Table 2, models 3 and 4). We also adjusted
our results for relevant sociodemographic and
lifestyle factors that could potentially explain
the association between high CRP and de-
pression, and took into account the potential
role of antidepressant treatment in changing
CRP concentration (Lanquillon et al. 2000),
although this seems to have had limited impact
on the association between CRP and depression
(Table 2, model 2). Importantly, the use of a
high-sensitivity assay to determine the serum
concentration of CRP enhanced the study’s
ability to investigate the association between
CRP and depressive symptoms.
We acknowledge that we cannot infer caus-
ality between the factors under investigation
because of the cross-sectional nature of the
study. Only a very small proportion of men in
our sample had depression but no signiﬁcant
physical co-morbidity (0.4%), which limited
the power of the study to investigate the inde-
pendent association between high CRP and
depression. Notwithstanding, the distribution
of CRP concentration according to group
membership, as outlined in Fig. 1, is entirely
consistent with the hypothesis that CRP con-
centration is not independently associated with
depression in older men. There is also evidence
that our older men with depression were less
likely to agree to a blood test, and that those
who did not have a blood test had greater co-
morbidity (higher weighted Charlson index).
This would have biased our results towards a
healthier sample and diminished our ability to
adjust the analyses for the eﬀect of poor physi-
cal health on any association between de-
pression and CRP concentration. The diagnosis
of ‘clinically signiﬁcant depression’ in this study
was based on a relatively high cut-point for the
GDS-15. This approach aimed to increase the
speciﬁcity of the diagnosis of depression ac-
cording to accepted clinical criteria (Almeida &
Almeida, 1999). We recognize, however, that
our classiﬁcation of depression was not based
on a formal assessment of mental state leading
to the diagnosis of a depressive episode. As a
result, we cannot be certain that our ﬁndings
would be directly transferable to patients meet-
ing DSM-IV criteria for major depression or
ICD-10 criteria for depressive episode. O’Brien
et al. (2006) reported that their 20 women
with DSM-IV major depression experienced
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signiﬁcant decline in the concentration of CRP
after a 3-week treatment with various anti-
depressants in an open-label fashion. The au-
thors argued that their subjects were free of
signiﬁcant physical illness, but reported exceed-
ingly high mean CRP concentrations of 12.0
and 8.0 mg/l before and after treatment (ap-
proximate ranges: 5–22 and 4–15 mg/l respect-
ively). CRP concentrations greater than 10 mg/l
are indicative of acute infection or inﬂammation
(Pearson et al. 2003). In addition, the inves-
tigators used statistical parametric tests, but
it is unclear from the data provided whether this
was the most appropriate analytical approach.
We conducted a series of analyses to clarify
whether the association between CRP and de-
pression is particularly pertinent for severe cases
of depression (e.g. depression deﬁned by a GDS-
15 scoreo10). We found no evidence in support
of the existence of such an association. Finally,
we acknowledge that our study included only
men and that our ﬁndings may not necessarily
apply to women. As the results of previous stud-
ies have shown that high CRP is associated with
depression particularly in men (Table 3), it
seems improbable that CRP would have had a
greater independent role in the pathogenesis of
depression among women.
In conclusion, the physiological mechanisms
that ultimately lead to the onset and mainten-
ance of depressive symptoms in later life are yet
to be determined, but our results indicate that
high CRP is unlikely to play a signiﬁcant role in
that process.
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